对竞争性内源性RNAs (ceRNAs) 调节的致病机制在转移性三阴性乳腺癌 (mTNBC) 的高级见解
Amal Qattan1,2, Taher Al-Tweigeri3, Kausar Suleman3
1Department of Molecular Oncology, King Faisal Specialist Hospital and Research Centre, Riyadh 11211, Saudi Arabia.
Cancers
|September 14, 2024
概括
转移性三阴性乳腺癌 (mTNBC) 是具有攻击性和难以治疗的. 本综述探讨了微RNA和竞争性内源性RNA (ceRNA) 网络如何驱动mTNBC转移,提供治疗见解.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 遗传学 是一个遗传学.
背景情况:
- 三阴性乳腺癌 (TNBC) 是一种具有有限治疗点和显著异质性的侵袭性亚型.
- 转移,由表皮细胞-介质细胞过渡和干性驱动,是TNBC中死亡的主要原因.
- 目前对转移性TNBC (mTNBC) 的治疗方法不足,这凸显了对新型治疗策略的需求.
研究的目的:
- 审查翻译后调节,特别是微RNA和竞争性内源性RNA (ceRNA) 网络在mTNBC转移中的作用.
- 探索针对mTNBC中ceRNA网络的潜在治疗策略.
- 确定在mTNBC转移领域的知识差距和未来研究方向.
主要方法:
- 文献综述侧重于研究研究TNBC转移中的microRNA和ceRNA调节网络.
- 对导致mTNBC转移性表型的遗传和表观遗传机制的分析.
- 综合当前关于mTNBC.ceRNA变化的临床影响的知识.
主要成果:
- 微RNA和ceRNA网络的变化与TNBC中转移性表型的驱动有关,包括上皮细胞-介质细胞过渡,茎性,迁移和入侵.
- 这些监管网络代表了开发mTNBC新型治疗干预措施的有希望的途径.
- 尽管取得了进展,但关于向ceRNA网络的精确机制和临床翻译仍然存在重大知识差距.
结论:
- 微RNA和ceRNA网络的失调在mTNBC进展和转移中发挥着关键作用.
- 针对这些网络提供了一个潜在的治疗窗口,以改善mTNBC患者的临床结果.
- 需要进一步的研究来充分阐明这些复杂的调节机制,并将其转化为有效的临床应用.
相关概念视频
01:22MicroRNAs
21.2K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
21.2K
02:30Metastasis
5.5K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.5K
02:39lncRNA - Long Non-coding RNAs
8.5K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.5K
03:03mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
02:23Master Transcription Regulators
6.9K
Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
6.9K
02:38Mitogens and the Cell Cycle
6.4K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.4K